Marshall Wace
MGNX icon

Marshall Wace’s MacroGenics MGNX Stock Holding History

Marshall Wace’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.85M Buy
2,025,526
+740,963
+58% +$1.58M 0.01% 1226
2025
Q4 		$2.07M Buy
1,284,563
+655,028
+104% +$1.03M ﹤0.01% 1564
2025
Q3 		$1.06M Buy
629,535
+223,624
+55% +$362K ﹤0.01% 1918
2025
Q2 		$491K Buy
405,911
+106,883
+36% +$155K ﹤0.01% 2153
2025
Q1 		$380K Sell
299,028
-94,738
-24% -$247K ﹤0.01% 2182
2024
Q4 		$1.28M Buy
393,766
+12,250
+3% +$44.1K ﹤0.01% 1617
2024
Q3 		$1.26M Sell
381,516
-276,491
-42% -$1.08M ﹤0.01% 1557
2024
Q2 		$2.8M Buy
658,007
+621,232
+1,689% +$6.05M ﹤0.01% 1221
2024
Q1 		$541K Buy
+36,775
New +$556K ﹤0.01% 1900
2023
Q3 		– Sell
-85,829
Closed -$459K – 2496
2023
Q2 		$459K Sell
85,829
-172,119
-67% -$1.06M ﹤0.01% 2015
2023
Q1 		$1.85M Buy
+257,948
New +$1.55M ﹤0.01% 1497
2022
Q4 		– Sell
-238,299
Closed -$824K – 3225
2022
Q3 		$824K Sell
238,299
-456,645
-66% -$1.75M ﹤0.01% 2498
2022
Q2 		$2.05M Buy
+694,944
New +$3.65M ﹤0.01% 1970
2021
Q4 		– Sell
-20,051
Closed -$420K – 4133
2021
Q3 		$420K Buy
+20,051
New +$483K ﹤0.01% 2480
2021
Q1 		– Sell
-38,123
Closed -$871K – 2715
2020
Q4 		$871K Buy
+38,123
New +$878K ﹤0.01% 1266
2020
Q2 		– Sell
-63,476
Closed -$369K – 1806
2020
Q1 		$369K Buy
+63,476
New +$576K ﹤0.01% 1045
2019
Q2 		– Sell
-4,470
Closed -$80K – 1643
2019
Q1 		$80K Buy
+4,470
New +$77.3K ﹤0.01% 1470
2018
Q4 		– Sell
-21,663
Closed -$464K – 1721
2018
Q3 		$464K Buy
+21,663
New +$462K ﹤0.01% 942
2017
Q1 		– Sell
-181,267
Closed -$3.71M – 572
2016
Q4 		$3.71M Buy
181,267
+85,551
+89% +$2.15M 0.02% 536
2016
Q3 		$2.86M Sell
95,716
-26,714
-22% -$795K 0.02% 519
2016
Q2 		$3.3M Buy
122,430
+18,972
+18% +$428K 0.03% 483
2016
Q1 		$1.94M Buy
103,458
+9,749
+10% +$186K 0.02% 566
2015
Q4 		$2.9M Buy
93,709
+45,422
+94% +$1.38M 0.03% 489
2015
Q3 		$1.03M Buy
+48,287
New +$1.51M 0.01% 617
2014
Q2 		– Sell
-10,000
Closed -$278K – 1012
2014
Q1 		$278K Buy
+10,000
New +$353K 0.01% 709

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace's MGNX Position: Q1 2026 in Review

Marshall Wace increased its MacroGenics (MGNX) stake by 58% in Q1 2026, buying an estimated $1.58M and bringing the position to 2,025,526 shares worth $5.85M. The position accounts for 0.01% of the portfolio, ranked #1226.

Marshall Wace first reported a position in MGNX in Q1 2014 and has held it in 25 quarters since. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Marshall Wace held 2,025,526 shares of MacroGenics worth $5.85M as of Q1 2026.
  • Marshall Wace bought 740,963 MacroGenics shares in Q1 2026, an estimated $1.58M.
  • MacroGenics made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1226 holding.
  • Marshall Wace first reported a position in MacroGenics in Q1 2014 and has held it in 25 quarters since.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.